SlideShare une entreprise Scribd logo
1  sur  50
Télécharger pour lire hors ligne
 National TB Control Program (RNTCP) was Launched in 1962
 RNTB Control Program –1993 /DOTS (Directly Observed
Treatment, Short-course)
 BCG:-Bacille Calmette Guerin- Live attenuated vaccine
 B.C.G vaccination Programme was launched in year :-1951
 At birth, dose of BCG vaccine is: 0.05 ml I/D until 1 month
 0.1 ml I/D after 1 month
 BCG vaccine dilute with NS
 Lung infection caused by M. tuberculosis, (Acid fast Bacilli)
 First discovered in 1882 by Robert Koch
 Transmitted by Inhalation of airborne droplets
(Talking - cough - sneezing – laughing).
 Mycobacterium tuberculosis infects about 35% world’s population
Introduction:-
Risk Factors for Tuberculosis
 Substance abuse
 DM, HIV, infection
 Anti- rejection drug
 Child younger than 5 years of age
 Drinking unpasteurized milk if cow is infected with bovine
tuberculosis
 Primarily affects pulmonary system, especially upper lobes
 Acute TB: Primary lesion
 Chronic TB: Progressive, re-injection & reactivation of primary lesions
after mouths or years. common in adults.
 Swallowing infectious sputum may cause/lead to laryngeal.
oropharyngeal or intestinal TB.
 Extra-pulmonary TB- Involves bone, kidneys
Types of TB
 Classical Sign –
◦ Progressive Cough (2 wks)
◦ Night Sweat/Sleep hyper-hidrosis
◦ Weight loss
◦ Low-grade fever.
 1st Symptoms:-A cough with expectoration of mucoid
sputum
C/F:-
◦ Ghon's complex :-lesion seen in lung that is
caused by TB
◦ (1to 1.5-cm area of gray white inflammation )
 An individual who received a BCG vaccine will
have a positive tuberculin skin test result &
should be evaluated for TB with a chest x-ray.
 Chest x-ray- Active or calcified lession
D/E:-
 Tuberculin Test /Mauntoux- test/ Mendel-
Mantoux test/ Pirquet test (1907)
 Injection of PPD (Purified Protein Derivative)
 M. tuberculosis, heating to 100 °C to kill bacilli &
subsequent filtering
 Store temp 2-8 °C
 I/D, dose – 0.1ml (5 TU tuberculin units) to Inner
surface of forearm.
(Indicate exposure to tubercle bacilli)
 Determination: after 48-72
hrs
 10 mm or greaten Positive
 6-9 mm Doubtful
 <6mm Negative
 5 mm for inmuno-
compromissed client, HIV
positive
 5 mm for inmuno-compromissed client, HIV
positive
 Find out it:-
 Heaf gun
Heaf test/ Ster-needle test:-Determine whether or not
children had been exposed to TB infection
 Administered by a Heaf gun
 Gun injected PPD
 Test was read B/W 2 & 7 days later
 Tine test:- Multiple-puncture tuberculin skin test
 Read 48 to 72 hours later
 Quouti FERON Gold Test- (1 mL) A blood analysis
test by interferon-gamma (IFN-y ) release assay,
 Results can be available in 24 hours
 More specific than tuberculin test.
 Sputum Culture- 3 Continuum sample Confirms
the diagnosis
 NPO past midnight in preparation for early
morning sputum collection

Spontaneously expectorated sputum:-3
consecutive morning sputum's

Induced sputum:- Nebulizer of 3% saline

Ziehl-Neelsen stain done of smear (Acid fast)

Fix Smear
Put Carbol fuchsin & heat smear until steam comes
out (but don’t boil & dry )
Place slide for 5-10 min. (wash smear with water )
Put 3ml HCL acid & 97% Ethanol solution
put malachite green dye (Wash)
dry slide & see under microscope
Methods
Acid fast Bacilli (Red Color)
Treatment
 Initial treatment 2 months
 (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide daily for 2
months
 Followed by 4 months of Isoniazid & Rifampicin given 3 times
a week
 Bacteriostatic” means that the agent prevents the
growth of bacteria Eg Ethambutol
 Bactericidal” means that it kills bacteria Eg
 Initial treatment 2 months
 (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide
daily for 2 months
 Followed by 4 months of Isoniazid & Rifampicin
given 3 times a week
 Bacteriostatic” means that agent prevents growth of
bacteria Eg Ethambutol
 Bactericidal” means that it kills bacteria Eg
Management:-
 First line drugs for TB "RIPE"
1.Isonizide (INH):- Batctericidal (Interfere with Cell wall
synthesis)Most common medication used for treatment of TB
 Adult :- 300mg/day
 Child :- 15 mg/kg/day
S/E:-
 I:-Iron accumulation in mitochondria is called Sideroblastic anemia
 N:-Neuropathy Peripheral (Affect CNS )
 H:-Hepatitis
 Vitamin B6 deficiency
 Note:-
 A client with a positive skin test for TB isn’t
showing signs of active disease.
 Prevent development of active TB, client should
be treated with Isoniazid, 300 mg daily,
for 9-12 month
 Note:-Safe to use during pregnancy
 Nurses role:-
 Administer isoniazid 1 hour before or 2 hours
after a meal because food may delay absorption.
 Administer at least 1 hour before Antacids
 Administer pyridoxine as prescribed to reduce
risk of neurotoxicity.
2.Rifampicine (Rifadin )-Batctericidal (interfere
with RNA )
 Adult- 600mg (10mg/kg) ,,Child- 10-20 mg/kg day
 S/E- Red, orange urine, Thrombocytopenia, GI
upset, Hepatitis, RF, Fever ,Discoloration of body
fluid-:
 Drug interaction with – OCP (oral contraceptive pills), advice to
use alternative method
 N/R:-Take medication on empty stomach with 8
oz of water 1 hour before or 2 hours after meals
 Avoid taking antacids with medication.
3.Pyrazinamide (PZA)- Bactericidal
 Adult- 15-30 mg/kg/day(2gm), -50 70mg/kg/BD
 Child – 15-20 mg/kg/day
 S/E- Hepatitis, Rash, GI upset, hyperurecenia,
difficult to control glucose in DM.
4.Ethambutol (EMB)/ Myambutol:- Bacteriostatic
(Interfere with RNA synthesis )
 Adult- 40-50 mg/kg/day(2 gm)
 Child - 15-25 mg/kg/day
 S/E: Eye:- Decrease visual acuity
 Optic neuritis (2nd CN), Skin Rash
5.Streptomycin:-Bactericidal inhibits mycobacterial
protein synthesis
 Adult : 15 mg/kg/day (1 gm)
 Child 15 mg/kg/day (1 gm)
 S/E- Ototoxicity, (8th Cranial Nerve damage) ,
Vertigo ,Renal toxicity
 Second line drug= inhibits cell metabolism.
 1. Kanamycin - Ototoxic & nephrotoxic

2. Para-aminosalicylic acid causes GI disturbances,
hepatotoxic
 Was developed by Karel Styblo
 Dots program -1993
DOTS (Directly Observed Treatment, Short-Course),
also known as TB-DOTS
 Multidrug-resistant strain of tuberculosis
(MDR-TB):-
 TB does not respond to at
least isoniazid & rifampicin, 2 most
powerful anti-TB drugs
 Instruct client to increase rich in iron, protein, &
vitamin C food
 Cultures are negative, client is no longer
considered infectious & usually can return to
former employment
Nurse’s role:-

1. A staff nurse has a tuberculosis (TB) skin test of
16-mm induration. A chest radiograph is negative,
and the nurse has no symptoms of TB. The
occupational health nurse will plan on teaching the
staff nurse about the
a. Use and side effects of isoniazid (INH).
b. Standard four-drug therapy for TB.
c. Need for annual repeat TB skin testing.
d. bacille Calmette-Guérin (BCG) vaccine.

ANS: A
MCQ
3.Which action by the occupational health nurse at a
manufacturing plant where there is potential
exposure to inhaled dust will be most helpful in
reducing incidence of lung disease?
a. Teach about symptoms of lung disease.
b. Treat workers who inhale dust particles.
c. Monitor workers for shortness of breath.
d. Require the use of protective equipment.

ANS: D

4.The health care provider writes an order for
bacteriologic testing for a patient who has a
positive tuberculosis skin test. Which action will
the nurse take?
a. Repeat the tuberculin skin testing.
b. Teach about the reason for the blood tests.
c. Obtain consecutive sputum specimens from the
patient for 3 days.
d. Instruct the patient to expectorate three
specimens as soon as possible.
ANS: C
 5. The right forearm of a client who had a purified
protein derivative (PPD) test for tuberculosis is
reddened and raised about 3mm where the test
was given. This PPD would be read as having which
of the following results?
 a. Indeterminate
b. Needs to be redone
c. Negative d. Positive
 c. Negative
 6. A client with primary TB infection can expect to
develop which of the following conditions?
 a. Active TB within 2 weeks
b. Active TB within 1 month
c. A fever that requires hospitalization
d. A positive skin test
 d. A positive skin test
 A primary TB infection occurs when the bacillus has
successfully invaded the entire body after entering
through the lungs.
 7. A client with a positive Mantoux test result will
be sent for a chest x-ray. For which of the
following reasons is this done?
 a. To confirm the diagnosis
b. To determine if a repeat skin test is needed
c. To determine the extent of the lesions
d. To determine if this is a primary or secondary
infection
 c. To determine the extent of the lesions
8.A client is diagnosed with active TB and started
on triple antibiotic therapy. What signs and
symptoms would the client show if therapy is
inadequate?
 a. Decreased shortness of breath
b. Improved chest x-ray
c. Nonproductive cough
d. Positive acid-fast bacilli in a sputum sample
after 2 months of treatment.
 d. Positive acid-fast bacilli in a sputum sample
after 2 months of treatment.
 9. A client who is HIV+ has had a PPD skin test.
The nurse notes a 7-mm area of induration at the
site of the skin test. The nurse interprets the
results as:
 a. Positive
b. Negative
c. Inconclusive
d. The need for repeat testing.
 a. Positive
 It is a surgical procedure create opening through
neck into trachea (windpipe)
 Maintaining patent airway
TRACHEOSTOMY
 Burns of the airway
 Cancer in the neck
 Chronic lung disease, Coma
 Diaphragm dysfunction
 Injury to larynx
 Need for prolonged respiratory or ventilator
support
 Obstruction of the airway by a foreign body
 Vocal cord paralysis
 Note:-E.T. Tube cannot be inserted.
Indication:-
 Emergency & prophylactic.
 Temporary & permanent.
According to placement
 High ring (2nd & 3rd) Incision made above isthmus
 Low ring (3rd & 4th ) Incision made below isthmus
Type of tracheostomy
 Types of tracheostomy tube:-
 Double Lumen (Most commonly used) or single Lumen
tube
 Cuffed or non –cuffed tube
 Cuffed
 Cuffed (20mm of Hg)
 Check every 8 hrs
 Non –cuffed tube
 Used in school age children
 Fenestrated or non-fenestrated

 Between the 2nd & 3rd/3rd or 4th tracheal rings.
 Position:-Rose position
Site
 1st day on tracheotomy need suction every 30 mt
 Clean inner cannula if present.
 Remove disposable inner connula & put new.
 Care of non disposal inner cannula, remove &
place in soaking solution like H2O2 for 5 min &
rinse with saline.
Nursing Care -
 Change tracheotomy ties.
 Place 4x4" tracheotomy dressing.
 Cover the tracheotomy with moist gauze or cotton
 Normal tracheotomy cuff pressure Maintain at 18-
25mmHg
 Infection
 Pneumonia
 Hemorrhage
 Tracheal injury
 Obstruction
 Subcutaneous emphysema
 Pneumothorax

Tracheostomy complications

Contenu connexe

Tendances

Nasogastric tube (ryles tube intubation) by meghana c
Nasogastric tube (ryles tube intubation) by meghana cNasogastric tube (ryles tube intubation) by meghana c
Nasogastric tube (ryles tube intubation) by meghana cMEGHANA C
 
Tuberculosis | காசநோய் | Juhin J
Tuberculosis | காசநோய் | Juhin JTuberculosis | காசநோய் | Juhin J
Tuberculosis | காசநோய் | Juhin JJuhin J
 
Communicable Disease
Communicable DiseaseCommunicable Disease
Communicable DiseaseKailash Nagar
 
Communicable diseases
Communicable diseasesCommunicable diseases
Communicable diseasesZaeem Jifri
 
Prevention of Corona Virus
Prevention of Corona Virus  Prevention of Corona Virus
Prevention of Corona Virus Prof Vijayraddi
 
Nasogastric tube feeding
Nasogastric tube feedingNasogastric tube feeding
Nasogastric tube feedingJays George
 
Dengue, DENGUE FEVER, DHS
Dengue, DENGUE FEVER, DHSDengue, DENGUE FEVER, DHS
Dengue, DENGUE FEVER, DHSpankaj rana
 
Record and reports for nurses
Record and reports for nurses Record and reports for nurses
Record and reports for nurses DEEPARANI
 
Msn ist(gnm 2nd yr)
Msn ist(gnm 2nd yr)   Msn ist(gnm 2nd yr)
Msn ist(gnm 2nd yr) ShreyaYadav35
 
Fundamental of Nursing 4. : Vital Signs
Fundamental of Nursing 4. : Vital SignsFundamental of Nursing 4. : Vital Signs
Fundamental of Nursing 4. : Vital SignsParya J. Ahmad
 
Injection administration ppt
Injection administration pptInjection administration ppt
Injection administration pptanjalatchi
 
Gcs( GLASGOW COMA SCALE)
Gcs( GLASGOW COMA SCALE) Gcs( GLASGOW COMA SCALE)
Gcs( GLASGOW COMA SCALE) pankaj rana
 
Bed sores / decubitis ulcer / pressure sores
Bed sores / decubitis ulcer / pressure soresBed sores / decubitis ulcer / pressure sores
Bed sores / decubitis ulcer / pressure soresSiva Nanda Reddy
 

Tendances (20)

Nasogastric tube (ryles tube intubation) by meghana c
Nasogastric tube (ryles tube intubation) by meghana cNasogastric tube (ryles tube intubation) by meghana c
Nasogastric tube (ryles tube intubation) by meghana c
 
Tuberculosis | காசநோய் | Juhin J
Tuberculosis | காசநோய் | Juhin JTuberculosis | காசநோய் | Juhin J
Tuberculosis | காசநோய் | Juhin J
 
Chicken pox
Chicken poxChicken pox
Chicken pox
 
ENEMA
ENEMA ENEMA
ENEMA
 
Drug calculations
Drug calculationsDrug calculations
Drug calculations
 
Communicable Disease
Communicable DiseaseCommunicable Disease
Communicable Disease
 
Epidemiology of Malaria
Epidemiology of MalariaEpidemiology of Malaria
Epidemiology of Malaria
 
Oxygen administration
Oxygen administrationOxygen administration
Oxygen administration
 
Communicable diseases
Communicable diseasesCommunicable diseases
Communicable diseases
 
Prevention of Corona Virus
Prevention of Corona Virus  Prevention of Corona Virus
Prevention of Corona Virus
 
NurseReview.Org - Vital Signs
NurseReview.Org - Vital SignsNurseReview.Org - Vital Signs
NurseReview.Org - Vital Signs
 
Nasogastric tube feeding
Nasogastric tube feedingNasogastric tube feeding
Nasogastric tube feeding
 
Dengue, DENGUE FEVER, DHS
Dengue, DENGUE FEVER, DHSDengue, DENGUE FEVER, DHS
Dengue, DENGUE FEVER, DHS
 
Swine flu ppt
Swine flu pptSwine flu ppt
Swine flu ppt
 
Record and reports for nurses
Record and reports for nurses Record and reports for nurses
Record and reports for nurses
 
Msn ist(gnm 2nd yr)
Msn ist(gnm 2nd yr)   Msn ist(gnm 2nd yr)
Msn ist(gnm 2nd yr)
 
Fundamental of Nursing 4. : Vital Signs
Fundamental of Nursing 4. : Vital SignsFundamental of Nursing 4. : Vital Signs
Fundamental of Nursing 4. : Vital Signs
 
Injection administration ppt
Injection administration pptInjection administration ppt
Injection administration ppt
 
Gcs( GLASGOW COMA SCALE)
Gcs( GLASGOW COMA SCALE) Gcs( GLASGOW COMA SCALE)
Gcs( GLASGOW COMA SCALE)
 
Bed sores / decubitis ulcer / pressure sores
Bed sores / decubitis ulcer / pressure soresBed sores / decubitis ulcer / pressure sores
Bed sores / decubitis ulcer / pressure sores
 

Similaire à Tuberclasis

Revised National TB control Progrramme
Revised National TB control ProgrrammeRevised National TB control Progrramme
Revised National TB control ProgrrammePrithvipal Singh
 
communicable-disease-compiled-notes.pdf
communicable-disease-compiled-notes.pdfcommunicable-disease-compiled-notes.pdf
communicable-disease-compiled-notes.pdfssuser554241
 
Rational antibiotic therapy NEW
Rational antibiotic therapy  NEWRational antibiotic therapy  NEW
Rational antibiotic therapy NEWSandip Gupta
 
COMMUNICABLE-DISEASE-NURSING Reviewer.pdf
COMMUNICABLE-DISEASE-NURSING Reviewer.pdfCOMMUNICABLE-DISEASE-NURSING Reviewer.pdf
COMMUNICABLE-DISEASE-NURSING Reviewer.pdfHussainAlfadhli2
 
Tuberculosis2
Tuberculosis2Tuberculosis2
Tuberculosis2Deep Deep
 
12 Tuberculosis Tanweiping
12 Tuberculosis Tanweiping12 Tuberculosis Tanweiping
12 Tuberculosis Tanweipingghalan
 
Cases of-arthropod-borne-diseases
Cases of-arthropod-borne-diseasesCases of-arthropod-borne-diseases
Cases of-arthropod-borne-diseasesmonaaboserea
 
PULMONARY TUBERCULOSIS/DIRECT OBSERVED TREATMENT SHORT TERM-COURSE .pdf
PULMONARY TUBERCULOSIS/DIRECT OBSERVED TREATMENT SHORT TERM-COURSE  .pdfPULMONARY TUBERCULOSIS/DIRECT OBSERVED TREATMENT SHORT TERM-COURSE  .pdf
PULMONARY TUBERCULOSIS/DIRECT OBSERVED TREATMENT SHORT TERM-COURSE .pdfDolisha Warbi
 
Board review course badreddine- june 2015 id
Board review course  badreddine- june 2015 idBoard review course  badreddine- june 2015 id
Board review course badreddine- june 2015 idNAIF AL SAGLAN
 

Similaire à Tuberclasis (20)

Revised National TB control Progrramme
Revised National TB control ProgrrammeRevised National TB control Progrramme
Revised National TB control Progrramme
 
TB Basics of ATT.pdf
TB Basics of ATT.pdfTB Basics of ATT.pdf
TB Basics of ATT.pdf
 
Tb -copy
Tb  -copyTb  -copy
Tb -copy
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
communicable-disease-compiled-notes.pdf
communicable-disease-compiled-notes.pdfcommunicable-disease-compiled-notes.pdf
communicable-disease-compiled-notes.pdf
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Rational antibiotic therapy NEW
Rational antibiotic therapy  NEWRational antibiotic therapy  NEW
Rational antibiotic therapy NEW
 
Pulmonology
PulmonologyPulmonology
Pulmonology
 
TUBERCULOSIS
TUBERCULOSISTUBERCULOSIS
TUBERCULOSIS
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
COMMUNICABLE-DISEASE-NURSING Reviewer.pdf
COMMUNICABLE-DISEASE-NURSING Reviewer.pdfCOMMUNICABLE-DISEASE-NURSING Reviewer.pdf
COMMUNICABLE-DISEASE-NURSING Reviewer.pdf
 
Bordetella,
Bordetella,Bordetella,
Bordetella,
 
Pulmonary Tuberculosis
Pulmonary TuberculosisPulmonary Tuberculosis
Pulmonary Tuberculosis
 
TUBERCULOSIS
TUBERCULOSISTUBERCULOSIS
TUBERCULOSIS
 
Tuberculosis2
Tuberculosis2Tuberculosis2
Tuberculosis2
 
12 Tuberculosis Tanweiping
12 Tuberculosis Tanweiping12 Tuberculosis Tanweiping
12 Tuberculosis Tanweiping
 
TUBERCULOSIS. .pptx
TUBERCULOSIS.                      .pptxTUBERCULOSIS.                      .pptx
TUBERCULOSIS. .pptx
 
Cases of-arthropod-borne-diseases
Cases of-arthropod-borne-diseasesCases of-arthropod-borne-diseases
Cases of-arthropod-borne-diseases
 
PULMONARY TUBERCULOSIS/DIRECT OBSERVED TREATMENT SHORT TERM-COURSE .pdf
PULMONARY TUBERCULOSIS/DIRECT OBSERVED TREATMENT SHORT TERM-COURSE  .pdfPULMONARY TUBERCULOSIS/DIRECT OBSERVED TREATMENT SHORT TERM-COURSE  .pdf
PULMONARY TUBERCULOSIS/DIRECT OBSERVED TREATMENT SHORT TERM-COURSE .pdf
 
Board review course badreddine- june 2015 id
Board review course  badreddine- june 2015 idBoard review course  badreddine- june 2015 id
Board review course badreddine- june 2015 id
 

Plus de Dr Ashok dhaka Bishnoi (20)

Suctioning
SuctioningSuctioning
Suctioning
 
Intravenous therapy
Intravenous therapyIntravenous therapy
Intravenous therapy
 
Hospital
HospitalHospital
Hospital
 
Suctioning
SuctioningSuctioning
Suctioning
 
.catheterization
.catheterization.catheterization
.catheterization
 
Disorder of endocrine system
Disorder of endocrine systemDisorder of endocrine system
Disorder of endocrine system
 
PPT on Hypoparathyroidism akki
PPT on Hypoparathyroidism akkiPPT on Hypoparathyroidism akki
PPT on Hypoparathyroidism akki
 
Hyperparathyroidism
HyperparathyroidismHyperparathyroidism
Hyperparathyroidism
 
Hyperthyroidism
HyperthyroidismHyperthyroidism
Hyperthyroidism
 
Hypothyroidism
HypothyroidismHypothyroidism
Hypothyroidism
 
Renal calculi
Renal calculiRenal calculi
Renal calculi
 
PPT on Nervous System
PPT on Nervous SystemPPT on Nervous System
PPT on Nervous System
 
ppt on CNS
ppt on CNS ppt on CNS
ppt on CNS
 
Supervision santhosh
Supervision santhoshSupervision santhosh
Supervision santhosh
 
ppt on Brain
ppt on Brainppt on Brain
ppt on Brain
 
ppt on Quality assuranse
ppt on Quality assuranseppt on Quality assuranse
ppt on Quality assuranse
 
ppt on EYE
ppt on EYEppt on EYE
ppt on EYE
 
ppt of Sensory organ
ppt of Sensory organppt of Sensory organ
ppt of Sensory organ
 
Endocrine glands
Endocrine glandsEndocrine glands
Endocrine glands
 
Cardiac emergencies 2
Cardiac emergencies 2Cardiac emergencies 2
Cardiac emergencies 2
 

Dernier

Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxraviapr7
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 

Dernier (20)

Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 

Tuberclasis

  • 1.
  • 2.  National TB Control Program (RNTCP) was Launched in 1962  RNTB Control Program –1993 /DOTS (Directly Observed Treatment, Short-course)  BCG:-Bacille Calmette Guerin- Live attenuated vaccine  B.C.G vaccination Programme was launched in year :-1951  At birth, dose of BCG vaccine is: 0.05 ml I/D until 1 month  0.1 ml I/D after 1 month  BCG vaccine dilute with NS
  • 3.  Lung infection caused by M. tuberculosis, (Acid fast Bacilli)  First discovered in 1882 by Robert Koch  Transmitted by Inhalation of airborne droplets (Talking - cough - sneezing – laughing).  Mycobacterium tuberculosis infects about 35% world’s population Introduction:-
  • 4. Risk Factors for Tuberculosis  Substance abuse  DM, HIV, infection  Anti- rejection drug  Child younger than 5 years of age  Drinking unpasteurized milk if cow is infected with bovine tuberculosis
  • 5.  Primarily affects pulmonary system, especially upper lobes  Acute TB: Primary lesion  Chronic TB: Progressive, re-injection & reactivation of primary lesions after mouths or years. common in adults.  Swallowing infectious sputum may cause/lead to laryngeal. oropharyngeal or intestinal TB.  Extra-pulmonary TB- Involves bone, kidneys Types of TB
  • 6.  Classical Sign – ◦ Progressive Cough (2 wks) ◦ Night Sweat/Sleep hyper-hidrosis ◦ Weight loss ◦ Low-grade fever.  1st Symptoms:-A cough with expectoration of mucoid sputum C/F:-
  • 7. ◦ Ghon's complex :-lesion seen in lung that is caused by TB ◦ (1to 1.5-cm area of gray white inflammation )
  • 8.  An individual who received a BCG vaccine will have a positive tuberculin skin test result & should be evaluated for TB with a chest x-ray.  Chest x-ray- Active or calcified lession D/E:-
  • 9.  Tuberculin Test /Mauntoux- test/ Mendel- Mantoux test/ Pirquet test (1907)  Injection of PPD (Purified Protein Derivative)  M. tuberculosis, heating to 100 °C to kill bacilli & subsequent filtering  Store temp 2-8 °C  I/D, dose – 0.1ml (5 TU tuberculin units) to Inner surface of forearm. (Indicate exposure to tubercle bacilli)
  • 10.  Determination: after 48-72 hrs  10 mm or greaten Positive  6-9 mm Doubtful  <6mm Negative  5 mm for inmuno- compromissed client, HIV positive
  • 11.  5 mm for inmuno-compromissed client, HIV positive
  • 12.
  • 13.  Find out it:-  Heaf gun
  • 14. Heaf test/ Ster-needle test:-Determine whether or not children had been exposed to TB infection  Administered by a Heaf gun  Gun injected PPD  Test was read B/W 2 & 7 days later
  • 15.  Tine test:- Multiple-puncture tuberculin skin test  Read 48 to 72 hours later
  • 16.  Quouti FERON Gold Test- (1 mL) A blood analysis test by interferon-gamma (IFN-y ) release assay,  Results can be available in 24 hours  More specific than tuberculin test.
  • 17.  Sputum Culture- 3 Continuum sample Confirms the diagnosis  NPO past midnight in preparation for early morning sputum collection  Spontaneously expectorated sputum:-3 consecutive morning sputum's  Induced sputum:- Nebulizer of 3% saline  Ziehl-Neelsen stain done of smear (Acid fast) 
  • 18. Fix Smear Put Carbol fuchsin & heat smear until steam comes out (but don’t boil & dry ) Place slide for 5-10 min. (wash smear with water ) Put 3ml HCL acid & 97% Ethanol solution put malachite green dye (Wash) dry slide & see under microscope Methods Acid fast Bacilli (Red Color)
  • 19. Treatment  Initial treatment 2 months  (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide daily for 2 months  Followed by 4 months of Isoniazid & Rifampicin given 3 times a week  Bacteriostatic” means that the agent prevents the growth of bacteria Eg Ethambutol  Bactericidal” means that it kills bacteria Eg
  • 20.  Initial treatment 2 months  (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide daily for 2 months  Followed by 4 months of Isoniazid & Rifampicin given 3 times a week  Bacteriostatic” means that agent prevents growth of bacteria Eg Ethambutol  Bactericidal” means that it kills bacteria Eg Management:-
  • 21.  First line drugs for TB "RIPE" 1.Isonizide (INH):- Batctericidal (Interfere with Cell wall synthesis)Most common medication used for treatment of TB  Adult :- 300mg/day  Child :- 15 mg/kg/day S/E:-  I:-Iron accumulation in mitochondria is called Sideroblastic anemia  N:-Neuropathy Peripheral (Affect CNS )  H:-Hepatitis  Vitamin B6 deficiency
  • 22.  Note:-  A client with a positive skin test for TB isn’t showing signs of active disease.  Prevent development of active TB, client should be treated with Isoniazid, 300 mg daily, for 9-12 month  Note:-Safe to use during pregnancy
  • 23.  Nurses role:-  Administer isoniazid 1 hour before or 2 hours after a meal because food may delay absorption.  Administer at least 1 hour before Antacids  Administer pyridoxine as prescribed to reduce risk of neurotoxicity.
  • 24. 2.Rifampicine (Rifadin )-Batctericidal (interfere with RNA )  Adult- 600mg (10mg/kg) ,,Child- 10-20 mg/kg day  S/E- Red, orange urine, Thrombocytopenia, GI upset, Hepatitis, RF, Fever ,Discoloration of body fluid-:  Drug interaction with – OCP (oral contraceptive pills), advice to use alternative method  N/R:-Take medication on empty stomach with 8 oz of water 1 hour before or 2 hours after meals  Avoid taking antacids with medication.
  • 25. 3.Pyrazinamide (PZA)- Bactericidal  Adult- 15-30 mg/kg/day(2gm), -50 70mg/kg/BD  Child – 15-20 mg/kg/day  S/E- Hepatitis, Rash, GI upset, hyperurecenia, difficult to control glucose in DM.
  • 26. 4.Ethambutol (EMB)/ Myambutol:- Bacteriostatic (Interfere with RNA synthesis )  Adult- 40-50 mg/kg/day(2 gm)  Child - 15-25 mg/kg/day  S/E: Eye:- Decrease visual acuity  Optic neuritis (2nd CN), Skin Rash
  • 27. 5.Streptomycin:-Bactericidal inhibits mycobacterial protein synthesis  Adult : 15 mg/kg/day (1 gm)  Child 15 mg/kg/day (1 gm)  S/E- Ototoxicity, (8th Cranial Nerve damage) , Vertigo ,Renal toxicity
  • 28.  Second line drug= inhibits cell metabolism.  1. Kanamycin - Ototoxic & nephrotoxic  2. Para-aminosalicylic acid causes GI disturbances, hepatotoxic
  • 29.  Was developed by Karel Styblo  Dots program -1993 DOTS (Directly Observed Treatment, Short-Course), also known as TB-DOTS
  • 30.  Multidrug-resistant strain of tuberculosis (MDR-TB):-  TB does not respond to at least isoniazid & rifampicin, 2 most powerful anti-TB drugs
  • 31.  Instruct client to increase rich in iron, protein, & vitamin C food  Cultures are negative, client is no longer considered infectious & usually can return to former employment Nurse’s role:-
  • 32.  1. A staff nurse has a tuberculosis (TB) skin test of 16-mm induration. A chest radiograph is negative, and the nurse has no symptoms of TB. The occupational health nurse will plan on teaching the staff nurse about the a. Use and side effects of isoniazid (INH). b. Standard four-drug therapy for TB. c. Need for annual repeat TB skin testing. d. bacille Calmette-Guérin (BCG) vaccine.  ANS: A MCQ
  • 33. 3.Which action by the occupational health nurse at a manufacturing plant where there is potential exposure to inhaled dust will be most helpful in reducing incidence of lung disease? a. Teach about symptoms of lung disease. b. Treat workers who inhale dust particles. c. Monitor workers for shortness of breath. d. Require the use of protective equipment.  ANS: D 
  • 34. 4.The health care provider writes an order for bacteriologic testing for a patient who has a positive tuberculosis skin test. Which action will the nurse take? a. Repeat the tuberculin skin testing. b. Teach about the reason for the blood tests. c. Obtain consecutive sputum specimens from the patient for 3 days. d. Instruct the patient to expectorate three specimens as soon as possible. ANS: C
  • 35.  5. The right forearm of a client who had a purified protein derivative (PPD) test for tuberculosis is reddened and raised about 3mm where the test was given. This PPD would be read as having which of the following results?  a. Indeterminate b. Needs to be redone c. Negative d. Positive  c. Negative
  • 36.  6. A client with primary TB infection can expect to develop which of the following conditions?  a. Active TB within 2 weeks b. Active TB within 1 month c. A fever that requires hospitalization d. A positive skin test  d. A positive skin test  A primary TB infection occurs when the bacillus has successfully invaded the entire body after entering through the lungs.
  • 37.  7. A client with a positive Mantoux test result will be sent for a chest x-ray. For which of the following reasons is this done?  a. To confirm the diagnosis b. To determine if a repeat skin test is needed c. To determine the extent of the lesions d. To determine if this is a primary or secondary infection  c. To determine the extent of the lesions
  • 38. 8.A client is diagnosed with active TB and started on triple antibiotic therapy. What signs and symptoms would the client show if therapy is inadequate?  a. Decreased shortness of breath b. Improved chest x-ray c. Nonproductive cough d. Positive acid-fast bacilli in a sputum sample after 2 months of treatment.  d. Positive acid-fast bacilli in a sputum sample after 2 months of treatment.
  • 39.  9. A client who is HIV+ has had a PPD skin test. The nurse notes a 7-mm area of induration at the site of the skin test. The nurse interprets the results as:  a. Positive b. Negative c. Inconclusive d. The need for repeat testing.  a. Positive
  • 40.
  • 41.  It is a surgical procedure create opening through neck into trachea (windpipe)  Maintaining patent airway TRACHEOSTOMY
  • 42.  Burns of the airway  Cancer in the neck  Chronic lung disease, Coma  Diaphragm dysfunction  Injury to larynx  Need for prolonged respiratory or ventilator support  Obstruction of the airway by a foreign body  Vocal cord paralysis  Note:-E.T. Tube cannot be inserted. Indication:-
  • 43.  Emergency & prophylactic.  Temporary & permanent. According to placement  High ring (2nd & 3rd) Incision made above isthmus  Low ring (3rd & 4th ) Incision made below isthmus Type of tracheostomy
  • 44.  Types of tracheostomy tube:-  Double Lumen (Most commonly used) or single Lumen tube  Cuffed or non –cuffed tube  Cuffed  Cuffed (20mm of Hg)  Check every 8 hrs  Non –cuffed tube  Used in school age children  Fenestrated or non-fenestrated 
  • 45.
  • 46.  Between the 2nd & 3rd/3rd or 4th tracheal rings.  Position:-Rose position Site
  • 47.
  • 48.  1st day on tracheotomy need suction every 30 mt  Clean inner cannula if present.  Remove disposable inner connula & put new.  Care of non disposal inner cannula, remove & place in soaking solution like H2O2 for 5 min & rinse with saline. Nursing Care -
  • 49.  Change tracheotomy ties.  Place 4x4" tracheotomy dressing.  Cover the tracheotomy with moist gauze or cotton  Normal tracheotomy cuff pressure Maintain at 18- 25mmHg
  • 50.  Infection  Pneumonia  Hemorrhage  Tracheal injury  Obstruction  Subcutaneous emphysema  Pneumothorax  Tracheostomy complications